PARAMUS, NEW JERSEY, UNITED STATES, May 6, 2022 /EINPresswire.com/ — Liberyx Therapeutics, an innovative drug development company targeting rare pediatric diseases, today announced that it has completed its Series A fundraising to support the …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
